Effects of monoclonal antibodies against amyloid-β on clinical and biomarker outcomes and adverse event risks: A systematic review and meta-analysis of phase III RCTs in Alzheimer’s disease
Konstantinos Avgerinos, Luigi Ferrucci, Dimitrios Kapogiannis
Topics & Concepts
MedicineMeta-analysisAdverse effectDiseaseBiomarkerMonoclonal antibodyAmyloid βOncologyInternal medicineAntibodyImmunologyBiologyBiochemistryAlzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchMultiple Sclerosis Research Studies